Published in J Appl Physiol (1985) on October 01, 1996
Contrasting actions of endothelin ET(A) and ET(B) receptors in cardiovascular disease. Annu Rev Pharmacol Toxicol (2007) 1.74
The endothelin receptor antagonist bosentan restores gut oxygen delivery and reverses intestinal mucosal acidosis in porcine endotoxin shock. Gut (1998) 1.53
Endothelin receptors and pain. J Pain (2009) 1.27
Endothelin. Cell Mol Life Sci (2010) 1.10
Systemic ETA receptor antagonism with BQ-123 blocks ET-1 induced forearm vasoconstriction and decreases peripheral vascular resistance in healthy men. Br J Pharmacol (2001) 1.08
The cardiovascular physiology and pharmacology of endothelin-1. Adv Pharmacol (2010) 1.01
The role of the paracrine/autocrine mediator endothelin-1 in regulation of cardiac contractility and growth. Br J Pharmacol (2013) 1.00
Endothelin type A receptor antagonist normalizes blood pressure in rats exposed to eucapnic intermittent hypoxia. Am J Physiol Heart Circ Physiol (2008) 0.97
Positron emission tomography using 18F-labelled endothelin-1 reveals prevention of binding to cardiac receptors owing to tissue-specific clearance by ET B receptors in vivo. Br J Pharmacol (2005) 0.96
Gene expression of endothelin-1 and endothelin receptor a on monocrotaline-induced pulmonary hypertension in rats after bosentan treatment. Korean Circ J (2010) 0.94
Endothelin B receptors contribute to retinal ganglion cell loss in a rat model of glaucoma. PLoS One (2012) 0.94
Bosentan inhibits oxidative and nitrosative stress and rescues occlusive pulmonary hypertension. Free Radic Biol Med (2012) 0.93
Extracellular superoxide dismutase overexpression can reverse the course of hypoxia-induced pulmonary hypertension. Mol Med (2012) 0.92
TASK1 (K(2P)3.1) K(+) channel inhibition by endothelin-1 is mediated through Rho kinase-dependent phosphorylation. Br J Pharmacol (2012) 0.91
The role of endothelin-1 in pulmonary arterial hypertension. Glob Cardiol Sci Pract (2014) 0.89
Endogenous plasma endothelin concentrations and coronary circulation in patients with mild dilated cardiomyopathy. Heart (1999) 0.83
Cigarette smoke exposure up-regulates endothelin receptor B in human pulmonary artery endothelial cells: molecular and functional consequences. Br J Pharmacol (2010) 0.83
Ambrisentan reduces pulmonary arterial hypertension but does not stimulate alveolar and vascular development in neonatal rats with hyperoxic lung injury. Am J Physiol Lung Cell Mol Physiol (2013) 0.83
Therapeutic efficacy of TBC3711 in monocrotaline-induced pulmonary hypertension. Respir Res (2011) 0.81
Change in pharmacological effect of endothelin receptor antagonists in rats with pulmonary hypertension: role of ETB-receptor expression levels. Pulm Pharmacol Ther (2009) 0.80
Ambrisentan for the treatment of pulmonary arterial hypertension. Drug Des Devel Ther (2009) 0.79
Differentiated effects on splanchnic homeostasis by selective and non-selective endothelin receptor antagonism in porcine endotoxaemia. Br J Pharmacol (1999) 0.79
Molecular imaging of the pulmonary circulation in health and disease. Clin Transl Imaging (2014) 0.79
Rosiglitazone Attenuated Endothelin-1-Induced Vasoconstriction of Pulmonary Arteries in the Rat Model of Pulmonary Arterial Hypertension via Differential Regulation of ET-1 Receptors. PPAR Res (2014) 0.78
Endothelin A receptor antagonists in congestive heart failure: blocking the beast while leaving the beauty untouched? Heart Fail Rev (2001) 0.78
Black currant anthocyanins normalized abnormal levels of serum concentrations of endothelin-1 in patients with glaucoma. J Ocul Pharmacol Ther (2012) 0.78
Clinical pharmacokinetics and pharmacodynamics of the endothelin receptor antagonist macitentan. Clin Pharmacokinet (2015) 0.78
Effect of endothelin antagonists, including the novel ET(A) receptor antagonist LBL 031, on endothelin-1 and lipopolysaccharide-induced microvascular leakage in rat airways. Br J Pharmacol (2000) 0.77
Optimizing endothelin receptor antagonist use in the management of pulmonary arterial hypertension. Vasc Health Risk Manag (2008) 0.77
Endothelin receptor polymorphisms in the cardiovascular system: potential implications for therapy and screening. Heart Fail Rev (2014) 0.77
Fluorescence correlation spectroscopy in drug discovery: study of Alexa532-endothelin 1 binding to the endothelin ETA receptor to describe the pharmacological profile of natural products. ScientificWorldJournal (2012) 0.75
Selective endothelin-1 receptor type A inhibition in subjects undergoing cardiac surgery with preexisting left ventricular dysfunction: Influence on early postoperative hemodynamics. J Thorac Cardiovasc Surg (2010) 0.75
Safety and tolerability of bosentan in the management of pulmonary arterial hypertension. Drug Des Devel Ther (2009) 0.75
Novel 24-h ovine model of brain death to study the profile of the endothelin axis during cardiopulmonary injury. Intensive Care Med Exp (2015) 0.75
Therapeutic role of bosentan in hypertension: lessons from the model of perinephritic hypertension. Heart Fail Rev (2001) 0.75
Hemodynamic effects of bosentan in patients with chronic heart failure. Heart Fail Rev (2001) 0.75
Randomised controlled trial of laparoscopic versus mini cholecystectomy. The McGill Gallstone Treatment Group. Lancet (1992) 5.69
Plexin-neuropilin-1 complexes form functional semaphorin-3A receptors. Cell (1999) 3.84
Interferon response sequence potentiates activity of an enhancer in the promoter region of a mouse H-2 gene. Nature (1986) 3.73
Pituitary adenylate cyclase-activating polypeptide and its receptors: from structure to functions. Pharmacol Rev (2000) 3.24
The capillary and sarcolemmal barriers in the heart. An exploration of labeled water permeability. Circ Res (1977) 3.22
Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition. Endocr Relat Cancer (2005) 3.04
Gastric antral vascular ectasia: the watermelon stomach. Gastroenterology (1984) 3.03
The long QT syndrome in children. An international study of 287 patients. Circulation (1993) 2.31
Low bone mineral density and peripheral blood monocyte activation profile in calcium stone formers with idiopathic hypercalciuria. J Clin Endocrinol Metab (1997) 2.30
Predictive factors for spontaneous closure of atrial septal defects diagnosed in the first 3 months of life. J Am Coll Cardiol (1993) 2.27
Structure and in vitro transcription of a glycine tRNA gene from Bombyx mori. EMBO J (1984) 2.27
Inactivation of Rho signaling pathway promotes CNS axon regeneration. J Neurosci (1999) 2.13
Cyclosporine bone remodeling effect prevents steroid osteopenia after kidney transplantation. Kidney Int (2000) 1.99
Can ethnic differences in men's preferences for women's body shapes contribute to ethnic differences in female adiposity? Obes Res (1993) 1.97
Useful predictors of bile duct stones in patients undergoing laparoscopic cholecystectomy. McGill Gallstone Treatment Group. Ann Surg (1994) 1.77
On the uptake of materials by the intact liver. The transport and net removal of galactose. J Clin Invest (1973) 1.69
Vasomotor control of capillary transit time heterogeneity in the canine coronary circulation. Circ Res (1976) 1.65
Scalloped valvulae conniventes: an endoscopic marker of celiac sprue. Gastroenterology (1988) 1.60
hCGRP8-37, a calcitonin gene-related peptide antagonist revealing calcitonin gene-related peptide receptor heterogeneity in brain and periphery. J Pharmacol Exp Ther (1990) 1.60
Indicator dilution measurements of extravascular water in the lungs. J Clin Invest (1969) 1.51
Structure-activity profile of calcitonin gene-related peptide in peripheral and brain tissues. Evidence for receptor multiplicity. J Pharmacol Exp Ther (1989) 1.42
Calcitriol and calcium carbonate therapy in early chronic renal failure. Nephrol Dial Transplant (1995) 1.40
Postoperative evaluation after end-to-end subclavian-left coronary artery anastomosis in anomalous left coronary artery. J Thorac Cardiovasc Surg (1990) 1.39
[Factors in the progression of renal insufficiency during the 2 years preceding the use of dialysis]. Nephrologie (1999) 1.39
The isolation and characterization of bilirubin diglucuronide, the major bilirubin conjugate in dog and human bile. Biochem J (1976) 1.34
Neuropeptide Y and neuropeptide Y receptor subtypes in brain and peripheral tissues. Prog Neurobiol (1992) 1.33
Paracellin-1 is critical for magnesium and calcium reabsorption in the human thick ascending limb of Henle. Kidney Int (2001) 1.31
Monoclonal antibodies to rabbit progesterone receptor: crossreaction with other mammalian progesterone receptors. Proc Natl Acad Sci U S A (1983) 1.29
Effects of endothelin-1 on vascular permeability in the conscious rat: interactions with platelet-activating factor. Br J Pharmacol (1991) 1.27
Diet, vitamin D and vertebral mineral density in hypercalciuric calcium stone formers. Kidney Int (1991) 1.27
Oral contraceptive use and reproductive factors and risk of ovarian cancer in the European Prospective Investigation into Cancer and Nutrition. Br J Cancer (2011) 1.27
Role of ligandin in transfer of bilirubin from plasma into liver. Am J Physiol (1979) 1.27
The isolation and further characterization of the bilirubin tetrapyrroles in bile-containing human duodenal juice and dog gall-bladder bile. Biochem J (1977) 1.25
Adaptation of iso-tRNA concentration to mRNA codon frequency in the eukaryote cell. Biochimie (1979) 1.25
Capillary exchange modeling. Barrier-limited and flow-limited distribution. Circ Res (1970) 1.24
Randomised controlled trial of enalapril and beta blockers in non-diabetic chronic renal failure. BMJ (1994) 1.24
Transcapillary exchange in the working left ventricle of the dog. Circ Res (1971) 1.20
The inlet patch: heterotopic gastric mucosa in the upper esophagus. Gastroenterology (1985) 1.19
Kinetics of rubidium uptake in the working dog heart. Circ Res (1971) 1.19
One-step immunoaffinity purification of active progesterone receptor. Further evidence in favor of the existence of a single steroid binding subunit. Biochemistry (1985) 1.19
Red cell carriage of label: its limiting effect on the exchange of materials in the liver. Circ Res (1975) 1.19
Synthesis, biological activity and conformational analysis of cyclic GRF analogs. Int J Pept Protein Res (1988) 1.18
Stable multicopy vectors for high-level secretion of recombinant human serum albumin by Kluyveromyces yeasts. Biotechnology (N Y) (1991) 1.18
Behaviours in trematode cercariae that enhance parasite transmission: patterns and processes. Parasitology (1994) 1.16
PACAP protects cerebellar granule neurons against oxidative stress-induced apoptosis. Eur J Neurosci (2002) 1.16
The S. Cerevisiae HAP complex, a key regulator of mitochondrial function, coordinates nuclear and mitochondrial gene expression. Comp Funct Genomics (2003) 1.16
The isolation of an azobilirubin beta-D-monoglucoside from dog gall-bladder bile. Biochem J (1974) 1.15
A unified kinetic hypothesis of carrier mediated transport: its applications. Biophys J (1965) 1.14
Changes in the blood-brain barrier in hepatic coma after hepatectomy in the rat. Gastroenterology (1977) 1.14
A search for specific and common susceptibility loci for schizophrenia and bipolar disorder: a linkage study in 13 target chromosomes. Mol Psychiatry (2001) 1.13
Presynaptic inhibition by neuropeptide Y in rat hippocampal slice in vitro is mediated by a Y2 receptor. Br J Pharmacol (1991) 1.13
Terminology for mass transport and exchange. Am J Physiol (1986) 1.13
Constraints on the uptake of labeled palmitate by the heart. The barriers at the capillary and sarcolemmal surfaces and the control of intracellular sequestration. Circ Res (1977) 1.13
Lack of histological evidence of vitamin D abnormality in the bones of anephric patients. Clin Sci (1973) 1.11
High-level secretion of correctly processed recombinant human interleukin-1 beta in Kluyveromyces lactis. Gene (1991) 1.10
Effects of pituitary adenylate cyclase-activating polypeptide (PACAP) on corticotropin-releasing hormone (CRH) gene expression in the rat hypothalamic paraventricular nucleus. Brain Res (1997) 1.10
Effects of saturating metabolic uptake on space profiles and tracer kinetics. Am J Physiol (1983) 1.10
Androgens induce expression of SPAK, a STE20/SPS1-related kinase, in LNCaP human prostate cancer cells. Mol Cell Endocrinol (2001) 1.07
Comparative characterization and autoradiographic distribution of neuropeptide Y receptor subtypes in the rat brain. J Neurosci (1993) 1.07
Neurotrophic activity of pituitary adenylate cyclase-activating polypeptide on rat cerebellar cortex during development. Proc Natl Acad Sci U S A (1999) 1.07
Pituitary adenylate cyclase-activating polypeptide promotes cell survival and neurite outgrowth in rat cerebellar neuroblasts. Neuroscience (1997) 1.06
Converting enzyme inhibitor or AT1-receptor blocker for decreasing long-term mortality in patients with stroke history and renal dysfunction? Stroke (2003) 1.06
Endothelin-1 enhances neutrophil adhesion to human coronary artery endothelial cells: role of ET(A) receptors and platelet-activating factor. Br J Pharmacol (1999) 1.05
Esophageal achalasia associated with gastric carcinoma: lack of evidence for widespread plexus destruction. Can Med Assoc J (1975) 1.05
Inhibition of gastric secretion by omeprazole and efficiency of calcium carbonate on the control of hyperphosphatemia in patients on chronic hemodialysis. Artif Organs (1998) 1.04
Production of alginate beads by emulsification/internal gelation. I. Methodology. Appl Microbiol Biotechnol (1992) 1.04
Management of fetal tachyarrhythmia based on superior vena cava/aorta Doppler flow recordings. Heart (2003) 1.03
[Overdosage of metoclopramide in child. Apropos of 9 clinical cases]. Pediatrie (1970) 1.03
On the uptake of materials by the intact liver. The concentrative transport of rubidium-86. J Clin Invest (1973) 1.02
Characterization of CGRP1 and CGRP2 receptor subtypes. Ann N Y Acad Sci (1992) 1.02
Oral contraceptives, reproductive history and risk of colorectal cancer in the European Prospective Investigation into Cancer and Nutrition. Br J Cancer (2010) 1.01
Nonadrenergic and noncholinergic arterial dilatation and venoconstriction are mediated by calcitonin gene-related peptide1 and neurokinin-1 receptors, respectively, in the mesenteric vasculature of the rat after perivascular nerve stimulation. J Pharmacol Exp Ther (1992) 1.01
Characterization of ETB receptors mediating contractions induced by endothelin-1 or IRL 1620 in guinea-pig isolated airways: effects of BQ-123, FR139317 or PD 145065. Br J Pharmacol (1994) 1.01
Project Medishare: a volunteer program in international health at the University of Miami. Acad Med (2000) 1.01
Pituitary adenylate cyclase-activating polypeptide stimulates both c-fos gene expression and cell survival in rat cerebellar granule neurons through activation of the protein kinase A pathway. Neuroscience (1998) 1.01
Effect of exercise on dilution estimates of extravascular lung water and on the carbon monoxide diffusing capacity in normal adults. Circ Res (1975) 1.00
Comparative affinities and antagonistic potencies of various human calcitonin gene-related peptide fragments on calcitonin gene-related peptide receptors in brain and periphery. J Pharmacol Exp Ther (1991) 1.00
[Collapsing glomerulopathy and cytomegalovirus, what are the links?]. Presse Med (2000) 1.00
Limitations of tracer oxygen uptake in the canine coronary circulation. Circ Res (1985) 0.99
Potent and selective tools to investigate neuropeptide Y receptors in the central and peripheral nervous systems: BIB03304 (Y1) and CGP71683A (Y5). Can J Physiol Pharmacol (2000) 0.99
Metformin-associated lactic acidosis in diabetic patients with acute renal failure. A critical analysis of its pathogenesis and prognosis. Nephrol Dial Transplant (1994) 0.99
[Metoclopramide poisoning in children]. Nouv Presse Med (1972) 0.99
Ketodiet, physiological calcium intake and native vitamin D improve renal osteodystrophy. Kidney Int (1992) 0.98
Characterization of neuropeptide Y binding sites in rat brain membrane preparations using [125I][Leu31,Pro34]peptide YY and [125I]peptide YY3-36 as selective Y1 and Y2 radioligands. J Pharmacol Exp Ther (1995) 0.97
[Letter: Neonatal septicemia and meningitis caused by Levinea malonatica]. Nouv Presse Med (1975) 0.97
Characterization of melanotropin-release-inhibiting factor (melanostatin) from frog brain: homology with human neuropeptide Y. Proc Natl Acad Sci U S A (1991) 0.97
Endothelin-1 enhances vascular permeability in the rat heart through the ETA receptor. Eur J Pharmacol (1992) 0.97
Myxoedema coma: response of thyroid hormones with oral and intravenous high-dose L-thyroxine treatment. Intensive Care Med (1991) 0.97
A new locus on chromosome 12p13.3 for pseudohypoaldosteronism type II, an autosomal dominant form of hypertension. Am J Hum Genet (2000) 0.97
Changes in cardiac transcapillary exchange with metabolic coronary vasodilation in the intact dog. Circ Res (1983) 0.96
Acute pro-inflammatory actions of endothelin-1 in the guinea-pig lung: involvement of ETA and ETB receptors. Br J Pharmacol (1995) 0.96
Pituitary adenylate cyclase-activating polypeptide: focus on structure-activity relationships of a neuroprotective Peptide. Curr Med Chem (2009) 0.96
Orthodontic considerations in the treatment of maxillary impacted canines. Am J Orthod (1982) 0.96
Stimulation of the sympathetic perimesenteric arterial nerves releases neuropeptide Y potentiating the vasomotor activity of noradrenaline: involvement of neuropeptide Y-Y1 receptors. J Neurochem (1997) 0.96
Regulation of proopiomelanocortin gene expression by neuropeptide Y in the rat arcuate nucleus. Brain Res (1995) 0.95
The processes of cellular uptake and exchange in the liver. Fed Proc (1982) 0.95
Electrocardiographic depolarization and repolarization: long-term after Kawasaki disease. Pediatr Cardiol (2002) 0.95
Characterization of human beta-interferon-binding sites on human cells. J Biol Chem (1985) 0.94
Menopausal hormone therapy and new-onset diabetes in the French Etude Epidemiologique de Femmes de la Mutuelle Générale de l'Education Nationale (E3N) cohort. Diabetologia (2009) 0.94